Latest news
MapLight's schizophrenia candidate clears one bar but misses another - The Pharma LetterThe Pharma Letter · Tue, 28 Jul 2026 07:00:00 GMTNovel CSF Biomarker and Peptide Candidate Target Cognitive Symptoms of Schizophrenia - Psychiatric TimesPsychiatric Times · Tue, 28 Jul 2026 07:00:00 GMTMapLight’s Schizophrenia Candidate Has Mixed Results at Phase II - Inside Precision MedicineInside Precision Medicine · Mon, 27 Jul 2026 18:39:19 GMTMapLight Therapeutics' Lead Candidate Falls Meaningfully Short In Schizophrenia (MPLT) - Seeking AlphaSeeking Alpha · Mon, 27 Jul 2026 07:00:00 GMTMapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMT